» Articles » PMID: 31596966

Osteocalcin Regulates Arterial Calcification Via Altered Wnt Signaling and Glucose Metabolism

Abstract

Arterial calcification is an important hallmark of cardiovascular disease and shares many similarities with skeletal mineralization. The bone-specific protein osteocalcin (OCN) is an established marker of vascular smooth muscle cell (VSMC) osteochondrogenic transdifferentiation and a known regulator of glucose metabolism. However, the role of OCN in controlling arterial calcification is unclear. We hypothesized that OCN regulates calcification in VSMCs and sought to identify the underpinning signaling pathways. Immunohistochemistry revealed OCN co-localization with VSMC calcification in human calcified carotid artery plaques. Additionally, 3 mM phosphate treatment stimulated OCN mRNA expression in cultured VSMCs (1.72-fold, p < 0.001). Phosphate-induced calcification was blunted in VSMCs derived from OCN null mice (Ocn ) compared with cells derived from wild-type (WT) mice (0.37-fold, p < 0.001). Ocn VSMCs showed reduced mRNA expression of the osteogenic marker Runx2 (0.51-fold, p < 0.01) and the sodium-dependent phosphate transporter, PiT1 (0.70-fold, p < 0.001), with an increase in the calcification inhibitor Mgp (1.42-fold, p < 0.05) compared with WT. Ocn VSMCs also showed reduced mRNA expression of Axin2 (0.13-fold, p < 0.001) and Cyclin D (0.71 fold, p < 0.01), markers of Wnt signaling. CHIR99021 (GSK3β inhibitor) treatment increased calcium deposition in WT and Ocn VSMCs (1 μM, p < 0.001). Ocn VSMCs, however, calcified less than WT cells (1 μM; 0.27-fold, p < 0.001). Ocn VSMCs showed reduced mRNA expression of Glut1 (0.78-fold, p < 0.001), Hex1 (0.77-fold, p < 0.01), and Pdk4 (0.47-fold, p < 0.001). This was accompanied by reduced glucose uptake (0.38-fold, p < 0.05). Subsequent mitochondrial function assessment revealed increased ATP-linked respiration (1.29-fold, p < 0.05), spare respiratory capacity (1.59-fold, p < 0.01), and maximal respiration (1.52-fold, p < 0.001) in Ocn versus WT VSMCs. Together these data suggest that OCN plays a crucial role in arterial calcification mediated by Wnt/β-catenin signaling through reduced maximal respiration. Mitochondrial dynamics may therefore represent a novel therapeutic target for clinical intervention. © 2019 American Society for Bone and Mineral Research.

Citing Articles

Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases.

Patil R, Wang H, Kazaleh M, Ailawadi G, Salmon M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861173 PMC: 11768260. DOI: 10.3390/ph18010112.


OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3.

Li Y, Chen X, Xu X, Chen C, Min M, Liang D Theranostics. 2025; 15(3):1185-1204.

PMID: 39776804 PMC: 11700865. DOI: 10.7150/thno.98660.


From Cells to Plaques: The Molecular Pathways of Coronary Artery Calcification and Disease.

Mitsis A, Khattab E, Christodoulou E, Myrianthopoulos K, Myrianthefs M, Tzikas S J Clin Med. 2024; 13(21).

PMID: 39518492 PMC: 11545949. DOI: 10.3390/jcm13216352.


Placental Tissue Calcification and Its Molecular Pathways in Female Patients with Late-Onset Preeclampsia.

Ortega M, Pekarek T, De Leon-Oliva D, Boaru D, Fraile-Martinez O, Garcia-Montero C Biomolecules. 2024; 14(10).

PMID: 39456171 PMC: 11506500. DOI: 10.3390/biom14101237.


The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics.

Huang J, Hao J, Wang P, Xu Y Kidney Int Rep. 2024; 9(9):2596-2607.

PMID: 39291213 PMC: 11403042. DOI: 10.1016/j.ekir.2024.05.005.